Sopharma AD | Income Statement
Fiscal year is January-December. All values BGN Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
761
841
875
876
1,016
1,179
Cost of Goods Sold (COGS) incl. D&A
696
742
775
787
908
1,077
Gross Income
65
98
100
89
108
102
SG&A Expense
14
59
52
42
43
62
Unusual Expense
-
10
1
1
3
2
Non Operating Income/Expense
-
2
1
7
4
5
Interest Expense
9
11
12
13
11
11
Pretax Income
39
29
29
53
53
33
Equity in Affiliates
-
1
1
9
1
2
Consolidated Net Income
33
24
23
55
46
31
Net Income
29
20
21
51
40
28
Net Income After Extraordinaries
29
20
21
51
40
28
Net Income Available to Common
29
20
21
51
40
28
EPS (Basic)
0.23
0.16
0.17
0.39
0.31
0.23
Basic Shares Outstanding
127
127
129
129
129
126
EPS (Diluted)
0.23
0.16
0.17
0.39
0.31
0.23
Diluted Shares Outstanding
127
127
129
129
129
126
Other Operating Expense
-
3
7
4
7
8
Non-Operating Interest Income
6
5
7
7
5
4
Minority Interest Expense
3
4
1
4
6
2
About Sopharma AD
View Profile
